识别和验证主要生物标志物和潜在的治疗点,用于初级开角绿内障
Jian Wu1, Caixia Lin2, Chenlong Yang3,4
1Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, 100730, China.
Science China. Life sciences
|August 23, 2023
概括
这项研究确定了主要开角青光眼 (POAG) 的新生物标志物,包括FN1,GPX3和VAV3. 这些发现为这种导致失明的主要原因提供了潜在的治疗点.
科学领域:
- 眼科医生 眼科 眼科
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 主要开角青光眼 (POAG) 是全球不可逆转失明的主要原因.
- 驱动POAG致病的确切机制尚不清楚,这阻碍了有效的治疗开发.
- 目前对POAG的治疗选择有限,强调需要新的治疗策略.
研究的目的:
- 为了确定POAG.的新生物标志物.
- 为了发现POAG的潜在治疗点.
- 阐明POAG发展背后的分子机制.
主要方法:
- 使用了基因表达微阵列数据集 (GSE27276,GSE138125) 和单细胞RNA测序 (scRNA-seq) 数据 (GSE148371).
- 进行了差异基因表达 (DEG) 分析,功能丰富,蛋白质-蛋白质相互作用 (PPI) 网络分析和加权基因共同表达网络分析 (WGCNA).
- 通过单细胞分析,免疫光和定量实时PCR (qPCR) 验证了关键基因.
主要成果:
- 在POAG中确定了43个下调和32个上调的DEG,在免疫反应,氧化应激和内质网膜 (ER) 应激途径中得到丰富.
- 在PPI网络中,FN1和DUSP1成为了中央枢纽节点.
- 通过WGCNA确定GPX3和VAV3为枢纽基因,并通过qPCR验证;通过单细胞验证确认FN1,GPX3和VAV3是关键核心基因.
结论:
- FN1,GPX3和VAV3被确定为POAG病变发生过程中的关键核心基因.
- 这些已识别的基因代表POAG.潜在的新生物标志物和治疗点.
- 需要进一步的研究,以充分理解这些基因在POAG发育和进展中的作用.
相关概念视频
Open Angle Glaucoma: Treatment
477
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
477
Glaucoma: Overview
621
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
621
Angle Closure Glaucoma: Treatment
560
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560


